Merck KGaA (ETR:MRK)
Germany · Delayed Price · Currency is EUR 143.15
+0.30 (0.21%)
Jul 31, 2026, 5:35 PM CET
Merck KGaA Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 20,955 | 21,102 | 21,156 | 20,993 | 22,232 | 19,687 |
Revenue Growth | -1.69% | -0.26% | 0.78% | -5.57% | 12.93% | 12.28% |
Gross Profit Gross Profit Growth | 12,266 | 12,346 | 12,485 | 12,392 | 13,705 | 12,335 |
Operating Income Operating Income Growth | 3,532 | 3,601 | 3,645 | 3,609 | 4,474 | 4,179 |
Net Income Net Income Growth | 2,532 | 2,608 | 2,777 | 2,824 | 3,312 | 3,055 |
Earnings Per Share EPS Growth | 5.82 | 6.00 | 6.39 | 6.49 | 7.65 | 7.03 |
EPS Growth | -10.18% | -6.10% | -1.54% | -15.16% | 8.82% | 53.83% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Process Solutions Process Solutions Growth | 3,878 | 3,785 | 3,522 | 3,782 | 4,540 | - |
Life Science Services Life Science Services Growth | - | - | 721.8 | 792.2 | 942.7 | - |
Science & Lab Solutions Science & Lab Solutions Growth | - | - | 4,672 | 4,706 | 4,898 | - |
Oncology Oncology Growth | 1,885 | 1,926 | 2,010 | 1,819 | 1,683 | 1,411 |
Neurology & Immunology Neurology & Immunology Growth | 1,603 | 1,659 | 1,688 | 1,665 | 1,743 | 1,645 |
Fertility Fertility Growth | 1,418 | 1,457 | 1,528 | 1,547 | 1,446 | 1,337 |
Cardiovascular, Metabolism and Endocrinology Cardiovascular, Metabolism and Endocrinology Growth | 3,030 | 3,050 | 2,949 | 2,786 | 2,806 | 2,540 |
Other Healthcare Other Healthcare Growth | 328.4 | 328 | 280.5 | 235.4 | 161.4 | 156.5 |
Surface Solutions Surface Solutions Growth | - | - | 406.5 | 410.9 | 439.4 | 410.1 |
Semiconductor Solutions Semiconductor Solutions Growth | 2,485 | 2,496 | 2,631 | 2,479 | 2,674 | 2,150 |
Advanced Solutions Advanced Solutions Growth | 2,350 | 2,365 | - | - | - | - |
Discovery Solutions Discovery Solutions Growth | 2,800 | 2,829 | - | - | - | - |
Rare Diseases Rare Diseases Growth | - | 188.2 | - | - | - | - |
Optronics Optronics Growth | 753.5 | 774.2 | 748.3 | 769.6 | 899.6 | 1,046 |
Revenue (Total) Revenue (Total) Growth | 20,955 | 21,102 | 21,156 | 20,993 | 22,232 | 19,687 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,743 | 2,740 | 2,517 | 1,982 | 1,854 | 1,899 |
Total Debt Total Debt Growth | 12,038 | 11,968 | 10,301 | 9,941 | 10,428 | 10,801 |
Net Cash (Debt) Net Cash Growth | -9,295 | -9,228 | -7,784 | -7,959 | -8,574 | -8,902 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -21.36 | -21.22 | -17.90 | -18.31 | -19.72 | -20.47 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4,194 | 3,932 | 4,586 | 3,784 | 4,259 | 4,616 |
Capital Expenditures CapEx Growth | -1,551 | -1,585 | -1,702 | -1,807 | -1,531 | -1,066 |
Free Cash Flow Free Cash Flow Growth | 2,643 | 2,347 | 2,884 | 1,977 | 2,728 | 3,550 |
Free Cash Flow Growth | 8.27% | -18.62% | 45.88% | -27.53% | -23.16% | 72.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.54% | 58.51% | 59.01% | 59.03% | 61.65% | 62.66% |
Operating Margin | 16.86% | 17.06% | 17.23% | 17.19% | 20.12% | 21.23% |
Pretax Margin | 15.37% | 15.68% | 16.71% | 16.60% | 19.28% | 19.93% |
Profit Margin | 12.15% | 12.39% | 13.16% | 13.50% | 14.96% | 15.57% |
FCF Margin | 12.61% | 11.12% | 13.63% | 9.42% | 12.27% | 18.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.200 | 2.200 | 2.200 | 2.200 | 2.200 | 1.850 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 18.92% | 32.14% |
Dividend Yield | 1.54% | 0.53% | 0.47% | 0.45% | 0.30% | 0.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.56 | 20.43 | 21.89 | 22.20 | 23.65 | 32.29 |
Forward PE | 17.37 | 14.90 | 14.80 | 16.17 | 17.32 | 24.88 |
P/FCF Ratio | 23.55 | 22.71 | 21.09 | 31.69 | 28.83 | 27.80 |
PS Ratio | 2.97 | 2.53 | 2.88 | 2.98 | 3.54 | 5.01 |